Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands
London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (GHO), the European specialist investor in global healthcare, acknowledges the announcement from its portfolio company, Ardena, regarding a major investment to expand across Belgium, Sweden and The Netherlands. Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO), in partnership with GHO Capital, announced… read more
GHO Capital acquires Ardena, a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma.
London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, has acquired Ardena, a specialist contract development and manufacturing organisation (CDMO) focused on early phase drug development, from Mentha Capital and existing management. Ardena is a multi-service CDMO, assisting small-to-mid sized biopharma with services spanning the full development… read more